When President Obama signed the Affordable Care Act into law in March 2010, the promise was affordable coverage for millions of Americans who lacked it. Sixteen years later, roughly 20 million more people do have insurance — but the clearest financial winner of the Obamacare era is not a patient, a hospital, or a taxpayer....
Iowa now records the second-highest rate of new cancer diagnoses in the United States, trailing only Kentucky, and is one of only a handful of states where the rate is still climbing while the national rate falls. Much of the public debate has centered on the state’s intensive agriculture — and, increasingly, on glyphosate, the...
Just as a wave of public-health pressure pushes American consumers and food companies toward lower-sugar, less-processed products, the dessert chain Crumbl Cookies has introduced a beverage moving in the opposite direction. A line of customizable “dirty sodas” sold by the chain has drawn public attention after one option was reported to contain 186 grams of...
In December 2023, the U.S. Food and Drug Administration approved the first medicine built on CRISPR gene-editing technology. The decision did more than clear a single treatment. It established that a therapy which rewrites a patient’s DNA could move through the same regulatory pathway used for conventional drugs, and it signaled to investors, hospitals and...
New York is poised to become the second U.S. state, after California, to ban potassium bromate, red dye No. 3, and propylparaben from its food supply. The bill also closes a long-debated federal regulatory loophole — and could shape national manufacturing decisions well beyond the state line. On April 21, 2026, the New York State...
Introduction The U.S. Food and Drug Administration has approved the first FDA gene therapy for inherited deafness, a one-time treatment that restored measurable hearing in 80% of evaluable pediatric patients during clinical testing. The therapy, marketed as Otarmeni (lunsotogene parvec-cwha), targets a specific genetic cause of profound hearing loss tied to mutations in the OTOF...
Introduction President Donald Trump signed an executive order on April 18, 2026, directing the Food and Drug Administration to accelerate its review of certain psychedelic compounds, including ibogaine, for the treatment of serious mental illness. The order marks the first time the federal government has formally moved to expedite ibogaine FDA approval, a development that...
Who’s Funding It, Who’s Pushing It, and What’s Standing in the Way The lab-grown food movement has a new frontier target: your morning cup of coffee. What was once confined to speculative tech conferences and fringe food blogs is now attracting hundreds of millions in venture capital, strategic investment from global food giants, and enthusiastic...
When One Giant Swallows Another: Sysco’s Restaurant Depot Deal Could Kill the Variety on Your Plate The $29 billion acquisition making headlines on Wall Street may quietly reshape what ends up on your dinner table — and not in a good way. It happened fast. Just this week, Sysco — already the country’s largest provider...
The Body Keeps the Score As the Global Food Supply Transforms, What Happens to Human Nutrition, Metabolism, and Long-Term Health? The food supply is changing faster than our understanding of what that change means for the human body. We covered the mechanics last time — how industrial seed oils have saturated processed foods, how lab-grown...